Portfolio company
LipoScience
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops nuclear magnetic resonance diagnostic tests and clinical analysers for laboratories and physicians to manage patient cardiovascular and metabolic disease risks.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
numares AG
This company develops nuclear magnetic resonance diagnostic systems and metabolite-based tests for clinical laboratories and life science researchers.
Boston Heart Diagnostics
The company provides cardiovascular diagnostic tests and personalised nutrition programmes to healthcare providers and patients to manage heart disease risk.
CardioDx
This company produces a genomic blood test for clinicians to assess the likelihood of obstructive coronary artery disease in symptomatic, non-diabetic patients.
CardiNor
This company develops secretoneurin blood assays for laboratories and researchers to assess risk in patients with cardiovascular disease.
Ischemia Technologies
This company develops and manufactures in vitro diagnostic products for cardiovascular and acute care medicine to assist clinicians in detecting cardiac ischemia.
Molecular Stethoscope
This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
Limosa Immunodiagnostics
This company develops diagnostic tests for latent tuberculosis and other immune-related diseases for patients and healthcare providers.
